International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 12, 2020, after the close
10-Q filed Nov 12, 2020, 43 days after period end · 0001564590-20-053534
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $1.48M | $2.10M | $3.20M | $1.85M |
| Net Income | -$544.00K | $3.00K | $121.00K | -$2.16M |
| EPS Diluted | -$0.07 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| $0.00 |
| $0.02 |
| -$0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
